Search research articles
Contact Us
Filters
Showing results (121-130 of 230) with videos related to
Page
of 23
Sort By:
Journal of Hematology & Oncology
|
January 5, 2018
Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
Jiayi Yu, Xiaowen Wu, Junya Yan, et al.
Urologic Oncology
|
December 28, 2025
Disitamab vedotin with or without PD-1 inhibitors in pretreated patients with locally advanced or metastatic urothelial carcinoma: Identifying patients who derive additional benefit from immune combination therapy
Mengnan Qu, Jinchang Wei, Jiazhi Mo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 16, 2022
A first-in-human, phase 1a dose-escalation study of the selective MEK1/2 inhibitor FCN-159 in patients with advanced NRAS-mutant melanoma
Lili Mao, Jun Guo, Lingjun Zhu, et al.
Chinese Clinical Oncology
|
September 6, 2018
Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case report
Bixia Tang, Xinan Sheng, Yan Kong, et al.
Journal of Cancer
|
April 21, 2018
Increased <i>AURKA</i> Gene Copy Number Correlates with Poor Prognosis and Predicts the Efficacy of High-dose Interferon Therapy in Acral Melanoma
Junya Yan, Jiayi Yu, Xiaowen Wu, et al.
Cancer Science
|
April 17, 2018
High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis
Tianxiao Xu, Meng Ma, Zhihong Chi, et al.
International Journal of Ophthalmology
|
February 28, 2019
Attenuation of periostin in retinal Müller glia by TNF-α and IFN-γ
Ying-Qian Peng, Man-Jing Cao, Shigeo Yoshida, et al.
Oncology Letters
|
February 14, 2018
Clinical significance of BRAF<sup>V600E</sup> mutation in circulating tumor DNA in Chinese patients with melanoma
Huan Tang, Yan Kong, Lu Si, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 21, 2025
MARCO+ Tumor-Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell Carcinoma
Jiayuan Chen, Jiazhi Mo, Jinchang Wei, et al.
British Journal of Cancer
|
April 15, 2025
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors
Daphne Day, Vinod Ganju, Ki Chung, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 230) with videos related to
Sort By:
Page
of 23
Journal of Hematology & Oncology
|
January 5, 2018
Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
Jiayi Yu, Xiaowen Wu, Junya Yan, et al.
Urologic Oncology
|
December 28, 2025
Disitamab vedotin with or without PD-1 inhibitors in pretreated patients with locally advanced or metastatic urothelial carcinoma: Identifying patients who derive additional benefit from immune combination therapy
Mengnan Qu, Jinchang Wei, Jiazhi Mo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 16, 2022
A first-in-human, phase 1a dose-escalation study of the selective MEK1/2 inhibitor FCN-159 in patients with advanced NRAS-mutant melanoma
Lili Mao, Jun Guo, Lingjun Zhu, et al.
Chinese Clinical Oncology
|
September 6, 2018
Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case report
Bixia Tang, Xinan Sheng, Yan Kong, et al.
Journal of Cancer
|
April 21, 2018
Increased <i>AURKA</i> Gene Copy Number Correlates with Poor Prognosis and Predicts the Efficacy of High-dose Interferon Therapy in Acral Melanoma
Junya Yan, Jiayi Yu, Xiaowen Wu, et al.
Cancer Science
|
April 17, 2018
High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis
Tianxiao Xu, Meng Ma, Zhihong Chi, et al.
International Journal of Ophthalmology
|
February 28, 2019
Attenuation of periostin in retinal Müller glia by TNF-α and IFN-γ
Ying-Qian Peng, Man-Jing Cao, Shigeo Yoshida, et al.
Oncology Letters
|
February 14, 2018
Clinical significance of BRAF<sup>V600E</sup> mutation in circulating tumor DNA in Chinese patients with melanoma
Huan Tang, Yan Kong, Lu Si, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 21, 2025
MARCO+ Tumor-Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell Carcinoma
Jiayuan Chen, Jiazhi Mo, Jinchang Wei, et al.
British Journal of Cancer
|
April 15, 2025
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors
Daphne Day, Vinod Ganju, Ki Chung, et al.
Page
of 23